[Clinical analysis of intravenous urokinase treatment of 10 cases with Kawasaki disease complicated with thrombus in coronary aneurysm].
作者信息
Zhou Nan, Bao Ying, Zhang Hong-ai
出版信息
Zhonghua Er Ke Za Zhi. 2009 May;47(5):384-5.
PMID:19573413
Abstract
摘要
相似文献
1
[Clinical analysis of intravenous urokinase treatment of 10 cases with Kawasaki disease complicated with thrombus in coronary aneurysm].
Zhonghua Er Ke Za Zhi. 2009 May;47(5):384-5.
2
Low-dose i.v. urokinase for coronary thrombosis in Kawasaki disease.
Pediatr Int. 2019 Mar;61(3):302-303. doi: 10.1111/ped.13783. Epub 2019 Mar 10.
3
Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction.
Acta Paediatr Jpn. 1991 Feb;33(1):27-35. doi: 10.1111/j.1442-200x.1991.tb01516.x.
4
Intracoronary thrombolytic therapy in Kawasaki disease: treatment and prevention of acute myocardial infarction.
Prog Clin Biol Res. 1987;250:445-54.
5
6
Plasma exchange in Kawasaki disease.
Lancet. 1995 Nov 11;346(8985):1307. doi: 10.1016/s0140-6736(95)91916-3.
7
[Giant coronary thrombus as a complication of Kawasaki disease].
Orv Hetil. 1993 Oct 31;134(44):2431-3.
8
Intracoronary thrombus in an infant with Kawasaki disease and giant coronary aneurysm.
Acta Paediatr. 2013 May;102(5):e227-8. doi: 10.1111/apa.12177. Epub 2013 Feb 18.
9
[To attach great importance to clinical management of Kawasaki disease with coronary arterial lesions].
Zhonghua Er Ke Za Zhi. 2013 Aug;51(8):569-70.
10
Rupture of coronary aneurysm in Kawasaki disease.
Pediatr Int. 1999 Jun;41(3):318-20. doi: 10.1046/j.1442-200x.1999.01058.x.
引用本文的文献
1
Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential.
Chin Med. 2014 Jul 19;9:19. doi: 10.1186/1749-8546-9-19. eCollection 2014.
Zotero 插件